Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013–2016 West Africa Ebola outbreak in Guinea

BACKGROUND: As part of a Phase III trial with the Ebola vaccine rVSVΔG-ZEBOV-GP in Guinea, we invited frontline workers (FLWs) to participate in a sub-study to provide additional information on the immunogenicity of the vaccine. METHODS: We conducted an open‐label, non‐randomized, single-arm immunog...

Descripción completa

Detalles Bibliográficos
Autores principales: Boum, Yap, Juan-Giner, Aitana, Hitchings, Matt, Soumah, Aboubacar, Strecker, Thomas, Sadjo, Mariama, Cuthbertson, Hannah, Hayes, Peter, Tchaton, Marie, Jemmy, Jean-Paul, Clarck, Carolyn, King, Deborah, Faga, Elisabetta Maria, Becker, Stephan, Halis, Bassam, Gunnstein, Norheim, Carroll, Miles, Røttingen, John-Arne, Kondé, Mandy Kader, Doumbia, Moise, Henao-Restrepo, Ana-Maria, Kieny, Marie-Paule, Cisse, Mohamed, Draguez, Bertrand, Grais, Rebecca F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306162/
https://www.ncbi.nlm.nih.gov/pubmed/32499066
http://dx.doi.org/10.1016/j.vaccine.2020.04.066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306162/
https://www.ncbi.nlm.nih.gov/pubmed/32499066
http://dx.doi.org/10.1016/j.vaccine.2020.04.066

Ejemplares similares